Search results
Neurocrine Biosciences, Inc.'s (NASDAQ:NBIX) Stock On An Uptrend: Could Fundamentals Be Driving The...
Simply Wall St. via Yahoo Finance· 2 years agoMost readers would already be aware that Neurocrine Biosciences' (NASDAQ:NBIX) stock increased...
Neurocrine Biosciences (NASDAQ:NBIX) shareholders have endured a 28% loss from investing in the...
Simply Wall St. via Yahoo Finance· 11 months agoAs an investor its worth striving to ensure your overall portfolio beats the market average. But in...
Investors one-year returns in Neurocrine Biosciences (NASDAQ:NBIX) have not grown faster than the...
Simply Wall St. via Yahoo Finance· 1 year agoIt hasn't been the best quarter for Neurocrine Biosciences, Inc. (NASDAQ:NBIX) shareholders, since...
Ironwood's (IRWD) Q3 Earnings Beat, Linzess Volume Grows
Zacks via Yahoo Finance· 2 years agoIronwood Pharmaceuticals, Inc. IRWD reported adjusted earnings of 28 cents per share in...
Dow Jones Futures: Stocks At Key Levels Despite Microsoft; Beware Doing This
Investor's Business Daily· 1 year agoDow Jones futures were little changed early Thursday, along with S&P 500 futures and Nasdaq futures....
Despite Neurocrine's Epilepsy Drug Missing Primary Goal In Pediatric Trial, Analyst Sees Strong...
Benzinga via Yahoo Finance· 2 years agoNeurocrine Biosciences Inc's (NASDAQ: NBIX) NBI-827104 did not meet its primary endpoint in the...